Description
Behavioral health disorders including dementia affect 65–90% of the CDC-estimated 1.5 million nursing home residents residing in 15,600 nursing homes across the United States. However, despite this, nursing home staff are often ill equipped to meet the mental health needs of their residents. Studies report that more than half of nursing homes do not have adequate access to psychiatric consultation and three quarters are unable to obtain consultation and educational services for behavioral problems. The need for improved access to and quality of mental health services within nursing homes remains a pressing concern today. The aims of this session are to characterize the burden of mental illness in nursing home residents in the US and to describe the cutting-edge efforts to deliver psychiatric services to nursing homes by leveraging technology. Based on the latest data, Drs. Briana Mezuk, Glen Xiong, and Elizabeth Santos will present on novel approaches to research and clinical care of mental illness in nursing home by incorporating data science and leveraging technology.
UAN: JA4008163-9999-20-038-H04-P
Activity Type: Knowledge Based
Objectives
- Audience will be able to estimate the prevalence of mental illness and incidence of suicides in nursing homes in US.
- Audience will be able to discuss the shortage of available mental health service resources in support of nursing homes in US.
- Audience will be able to compare and contrast synchronous and asynchronous forms if telepsychiatry delivered in nursing homes.
- Audience will be able to identify the multiple components of the URMC Geriatric Telepsychiatry Model implemented to support many nursing homes in New York State.
Acknowledgements, Accreditation, and Disclosures
Acknowledgement of Support
This webinar is supported in part by an unrestricted educational grant provided by the American Board of Psychiatry and Neurology (ABPN).
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for Geriatric Psychiatry. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
Amedco LLC designates this activity for a maximum of1.0 ANCC contact hours.
Pharmacists
Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.
Psychologists
Amedco LLC designates this activity for a maximum of 1.0 psychologist contact hours.
Social Workers
As a Jointly Accredited Organization, Amedco is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Amedco maintains responsibility for this course. Social workers completing this course receive 1.0 GENERAL continuing education credits.
Disclosures
Disclosure of Relevant Financial Relationships:
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1--6.2, 6.5)
All individuals in a position to control the content of CE are listed in the program book. If their name is not listed below, they disclosed that they had no relevant financial relationships.
- Martin Steinberg
- No relevant financial relationship exists
- Paul Rosenberg
- Cerevel - consultant
- Acadia - consultant
- Bioxcel - consultant
- Deirdre Johnston
- MIND at Home Newco – Founder
- Translation partnership with healthcare organization subject to NDA
- Brent Forester
- Acadia Pharmaceuticals – Consultant
- Eli Lilly - Research Grant Site Principal Investigator
- Biogen - Research Grant Site Principal Investigator; Consultant
- Eisai - Research Grant Site Principal Investigator